Counter-productive: the impact of ignoring carer productivity

Glass facade reflecting a colorful sunset with pink, orange, and blue skies.

Caring for a loved one often carries a quiet cost to an individual’s career and wellbeing. Yet this cost is rarely considered when assessing which treatments represent good value.

Unpaid care is increasingly common and balancing it alongside paid and unpaid work can prove challenging to individuals, employers and the wider economy. A recent report from Carers UK estimates that 11 million adults are providing unpaid care in the UK. Of these, 6.7 million try to combine caring with paid employment, almost 40% more than in 2019. The strain of balancing both is showing in carers (in)ability to remain in employment. An estimated 4.1 million people in the UK have reduced their working hours as a result of competing caring responsibilities, while 3.3 million people left work altogether to provide care. And the rate is only accelerating. In the last two years, the equivalent of approximately 1,500 people a day left work to provide care, almost three times as many as in 2019. 

The increasing burden on unpaid carers is largely attributable to people living longer, and with more long-term conditions and disabilities. The social care system is facing pressure, and individuals often have little real choice but to step in to look after family and friends. As the system struggles to keep pace with demand for out-of-hospital care, more of the gap is filled informally, by people who are also balancing a career themselves.  

The Department for Business and Trade puts a number on what this means for the country. Unpaid carers cutting their working hours, delaying their return to work, or leaving employment altogether is estimated to cost the economy £37 billion a year in lost economic activity. That figure is often framed as paid carer leave or flexible working. But that framing risks underselling what is actually happening, where a resource-stretched health and social care system is, in effect, outsourcing care to unpaid carers, who are left to balance their jobs alongside caring for family or friends. It should therefore also be read as a case for recognising the effects of caring on workforce productivity in how we value medicines through health technology assessment (HTA).

The case for counting carer productivity 

Treatments for the conditions that create the need for intensive unpaid care, such as dementia, strokes, and frailty-related illnesses, don’t just benefit the patient. They also relieve the carer. Each day that a treatment delays or avoids some caring burden is a day someone can stay in, or return to, paid work. Treatments that reduce or eliminate the need for carers to cut back on their economic activity could return up to £37 billion to the economy. That benefit should be recognised as part of the value of such treatments. 

Addressing potential objections 

Objections to considering productivity in HTA generally focus on fairness, specifically that it could bias resource allocations towards working-age populations, and especially higher-income patients. OHE has previously addressed criticism around this subject. This is not an argument for introducing productivity into HTA from scratch as this is already counted, at least for patients, in many frameworks. The relevant question here is not whether productivity should count at all, but whose productivity counts. To the extent that there are equity concerns around consideration of productivity, excluding carer productivity from HTA calculations is likely to lead to greater rather than less inequity. Treatments for conditions that disproportionately affect people outside paid work, such as retired patients, will typically generate limited paid productivity gains (although unpaid productivity gains may still be substantial). If carer paid productivity is also excluded, these treatments receive no productivity credit at all. This could potentially increasing inequity in the group most likely to be disadvantaged by valuing productivity, the very inequity the fairness objection was meant to guard against.

The £37 billion figure cited earlier illustrates that informal care is not a ‘free resource’, but a real and substantial opportunity cost that currently falls on all of society in the form of forgone paid and unpaid activity and an associated loss on potential tax revenues. Valuing carer productivity in HTA, alongside patient productivity, would help ensure that carers’ time is valued and used as efficiently as possible from a societal perspective. From an equity perspective, it would also ensure that treatments for diseases that affect older patient cohorts are assessed on a level playing field relative to treatments for diseases affecting working-age cohorts by capturing the full range of productivity effects.

The economic impact of unpaid care is substantial, and is likely to grow as a greater share of the population ages. Continuing to value patient productivity while ignoring the carers’ may become an increasingly difficult position for HTA agencies to defend.

You may also be interested in